3results about How to "Low variability" patented technology

There is described a device (100) for planning a transfer line (26) of an analysis device (10), the device (100) comprising a holding element (110) for holding the transfer line (26), and a coupling element (120) for magnetically coupling with the holding element (110) and to the analysis device (10). In addition, analysis devices and methods are described.

This invention discloses a visual detection method for part contours based on local tracking path planning. The method is as follows: 1. Establish the measurement coordinate system required for visual measurement. 2. Obtain the coarse measurement panoramic contour. Take the circumscribed rectangle of the coarse measurement panoramic contour in the image as the detection area. 3. Preprocessing of the tiled intersection path. 4. Perform local measurement path planning using the A-GSAA algorithm. 5. The probe device performs local tracking measurement according to the optimal measurement path, obtaining n local images; the n local images are stitched together using overlapping parts to extract the contour, obtaining the fine measurement contour. This invention uses A-GSAA to plan the measurement path for the local image shooting points extracted by tiled intersection, and adopts adaptive crossover probability and mutation probability. In the early stage of iteration, the crossover probability and mutation probability are maintained at a high level to promote the generation of new individuals, and the crossover probability and mutation probability are reduced in the later stage of iteration to avoid destroying good individuals.

The invention discloses an application of a compound 3546847 in preparation of anti-staphylococcus aureus hemolysin medicines, and belongs to the field of microbial infectious diseases and medicines. The invention finds that the compound 3546847 can neutralize the toxicity of staphylococcus aureus hemolysin, and has a protective effect on MRSA staphylococcus aureus USA300 infected mice. The compound 3546847 can be applied to preparation of anti-staphylococcus aureus hemolysin medicines and medicines for preventing or treating staphylococcus aureus infection. The new medicinal value of the compound 3546847 is found, and a new medicine for preventing and treating staphylococcus aureus infection is provided; the compound 3546847 can neutralize the main virulence factor of staphylococcus aureus, namely hemolysin, so as to relieve inflammatory injury.